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Abstract
Despite detailed studies on nitroxylcobalamin (CblNO) formation, the possible intracellular generation of CblNO via reduc-
tion of nitrocobalamin  (CblNO2) remains questionable. To study this further, spectroscopic studies on the reaction of  CblNO2 
with the intracellular antioxidant ascorbic acid  (HAsc−) were performed in aqueous solution at pH < 5.0. It was found that 
nitroxylcobalamin is the final product of this interaction, which is not just a simple reaction but a rather complex chemical 
process. We clearly show that an excess of nitrite suppresses the formation of CblNO, from which it follows that ascorbic 
acid cannot reduce coordinated nitrite. We propose that under the influence of ascorbic acid, nitrocobalamin is reduced to 
Cbl(II) and nitric oxide (·NO), which can subsequently react rapidly to form CblNO. It was further shown that this system 
requires anaerobic conditions as a result of the rapid oxidation of both Cbl(II) and CblNO.
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Introduction
Nitroxylcobalamin (CblNO, formally  CoIII–NO−) [1] is one 
of the most interesting forms of Vitamin  B12 that was shown 
to be stable in biological systems [2, 3]. Under physiologi-
cal conditions, CblNO can be produced in a very efficient 
reaction between the major intracellular form of Vitamin 
 B12r, viz. cob(II)alamin [4], and nitric oxide (·NO) for 
which k = 7.4 × 108  M−1  s−1 and KNO ≈ 1 × 108  M−1 at 
25 °C [5–7]. It has been postulated that cobalamins show 
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the potential to eliminate excess ·NO from organisms [8, 9] 
since the  CoIII–NO− complex can be protonated at neutral 
pH to form  CoIII–NOH, which in turn can undergo aquation 
to release HNO. The latter species is known to dimerize and 
decompose to water and gaseous  N2O in aqueous solution 
[10].
CblNO is extremely air sensitive [6, 11, 12] and in the 
presence of oxygen it rapidly oxidizes to nitrocobalamin 
 (CblNO2) [6, 11–13]. However, the oxidation of CblNO is 
not just a simple reaction [14]. According to Brasch et al., 
the mechanism of CblNO oxidation under certain condi-
tions is rather complex, with multiple products that can be 
formed [15]. Oxidation of CblNO is a reversible process in 
which  CblNO2 can be reduced by strong reducing agents to 
reform CblNO. Brasch et al. studied the reaction between 
 CblNO2 and one of the strongest intracellular antioxidants 
glutathione (GSH), as one of the possibilities to form CblNO 
[16]. An important conclusion from this work is that for a 
pH between 4 and 7, reduction of  CblNO2 to CblNO was 
not observed! Furthermore, the main product of this reac-
tion is glutathionylcobalamin (CblGS). The reported kinetic 
data suggest that the observed reaction is a two-step process 
which involves aquacobalamin  (CblOH2) as an intermedi-
ate that rapidly reacts with GSH to form CblGS (Scheme 1) 
[16].
Our recent study [17] showed that at neutral pH (pH 7.2, 
0.1 M Tris buffer, 25 °C),  CblNO2 can react with another 
biological reducing agent, ascorbic acid  (HAsc−), to form 
reduced cobalamin (Cbl(II)) as product, but not CblNO 
as was hoped. Kinetic data showed that both  CblNO2 and 
 CblOH2 present in an equilibrium mixture react with  HAsc−, 
but  CblOH2 reacts ca. two orders of magnitude faster than 
 CblNO2 (Scheme 2), i.e. k2 ≫ k3. Thus, on addition of ascor-
bic acid to the equilibrium mixture of  CblOH2 and  CblNO2, 
it reacts rapidly with  CblOH2 which in turn is reformed 
through the aquation of  CblNO2 (k1 = 1.4 × 10−2 s−1 at 
25 °C) and so represents the major reactive species in solu-
tion. Furthermore, in the presence of a large excess of nitrite 
the reduction of  CblOH2 can be drastically inhibited due to 
the formation of  CblNO2 [17]. Recent work in our labora-
tories indicated that this system shows a more interesting 
behavior under slightly different experimental conditions.
Experimental section
Materials
Hydroxocobalamin hydrochloride (HOCbl·HCl,  ≥  98%) 
was purchased from Sigma-Aldrich, sodium nitrite was pur-
chased from LPPH and ascorbic acid was obtained from Polfa 
Kraków. Acetic acid  (CH3COOH,  ≥ 99.5–99.9%) and sodium 
hydroxide (NaOH, ≥ 98.8%) were obtained from a range of 
suppliers (Sigma-Aldrich, Merck, Fisher Scientific or POCH). 
All chemicals used throughout this study were of analytical 
grade or better.
General methods
All solutions were prepared in de-ionized water using a water 
purification system. Strictly anaerobic solutions were prepared 
using appropriate air-free techniques and handling the solu-
tions in appropriate glassware. Oxygen-free argon or nitro-
gen was used to deoxygenate the reactant solutions. UV–Vis 
spectral measurements were carried out in screw-cap cuvettes 
equipped with a silicone septum. pH measurements were car-
ried out at room temperature using a HI 221 (Hanna Instru-
ments) pH-meter equipped with an AmpHel glass electrode 
filled with a 3 M KCl solution.
UV–Vis spectroscopy
UV–Vis spectra and kinetic data were recorded on Perkin 
Elmer Lambda 25 spectrophotometer equipped with a thermo-
stated (25.0 ± 0.1 °C) cell holder (Perkin Elmer PTP-6 Peltier 
System). All data were analyzed using Origin Lab software.
Scheme  1  Schematic presentation of the reaction between  CblNO2 
and GSH
Scheme  2  Suggested mechanism for the reaction between  CblNO2 
and  HAsc− at pH ~ 7
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Results and discussion
After completion of our studies at pH ~ 7, we decided to 
check the influence of ascorbic acid on the reaction with 
 CblNO2 at a more acidic pH ≤ 5, where ascorbic acid is 
mainly present in the mono-protonated form  HAsc− and 
the much weaker reducing agent  H2Asc, depending on the 
selected pH (pKa1 = 4.1 and pKa2 = 11.3 [18]). Under these 
conditions, mixtures of  H2Asc and  HAsc− have significantly 
weaker reducing properties than at pH ~ 7, where ascorbic 
acid is mainly present as  HAsc− with traces of the stronger 
reducing agent  Asc2− [18–23]. UV–Vis spectra recorded 
during the reaction between  CblNO2 and  HAsc− at pH < 5 
(0.1 M acetate buffer, 25 °C, Ar atmosphere) indicated that 
 CblNO2 (λmax = 354, 413 and 532 nm) is not converted to 
Cbl(II) as before [17], but appears to be converted directly 
to nitoxylcobalamin, CblNO (λmax = 316, 344 and 475 nm) 
[6] with isosbestic points at 335, 373, 490 nm (Fig. 1a). 
Under conditions of pH 4.3 (0.1 M acetate buffer, 25 °C, 
Ar atmosphere),  [CblNO2] = 8.6 × 10−5 M (obtained by 
mixing  CblOH2 and  NO2−,  [NO2−]/[CblOH2]  =  5) and 
 [HAsc−] = 8.6 × 10−4 M, CblNO was formed within 100 min 
from the start of the reaction. During the next 300 min prac-
tically no spectral changes were observed, from which we 
conclude that CblNO is stable in solution under the selected 
conditions (Fig. 1b). However, during the next 400 min the 
absorbance at 476 nm decreased to the initial value and the 
UV–Vis spectra clearly showed that  CblNO2 was reformed 
fully (isosbestic points at 335, 373, 490 nm) (Fig. 1c, d).
Further studies showed that CblNO was formed faster 
and remained for longer times in the reaction mixture when 
higher concentrations of  HAsc− were used (compare Fig. 2a, 
b and d), whereas increasing the nitrite concentration slowed 
down the conversion of  CblNO2 to CblNO (compare Fig. 2b 
and c). In a more detailed series of experiments, the nitrite 
concentration was varied over a wider concentration range 
while keeping the ascorbate concentration constant. The 
results reported in Figure S1 (Supporting Information) 
show that the initial phase of the reaction indeed slows 
down significantly on increasing the nitrite concentration. 
The kinetic data could be fitted best with a zero-order pro-
cess for the initial changes in absorbance with time, and the 
slopes of such plots as a function of  CblOH2 concentration 
show typical saturation kinetics (see Figure S1e). From the 
value of K = 1 × 105  M−1 (see Scheme 2) reported at 25 °C 
[17], it can be estimated that the concentration of  CblOH2 
in solution decreases from 1.95 × 10−6 to 4.97 × 10−7 M 
on increasing the nitrite concentration from 4.3 × 10−4 to 
1.72 × 10−3 M for the experiments reported in Figure S1. 
This clearly demonstrates the effect of the nitrite concentra-
tion on the rate of formation of CblNO. In the presence of 
a large excess of nitrite, no reaction was observed at all, 
Fig. 1  a Spectral changes 
observed for the reaction 
between  CblNO2 (8.6 × 10−5 M, 
obtained by mixing  CblOH2 and 
 NO2−,  [NO2−]/[CblOH2] = 5) 
and  HAsc− (8.6 × 10−4 M) at 
pH 4.3 (0.1 M acetate buffer, 
25 °C, Ar atmosphere) during 
the first 100 min, b between 100 
and 400 min, c between 400 and 
1200 min from the start of the 
reaction. Spectra were recorded 
every 1 min. d Plot of absorb-
ance at 476 nm vs. time 300 400 500 600
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suggesting that nitrite completely suppresses the formation 
of CblNO.
Additional studies were performed to check whether after 
almost 20 h from the start of the reaction, it is possible to 
reduce the final  CblNO2 product by the addition of an extra 
amount of ascorbic acid. Surprisingly, addition of an extra 
portion of  HAsc− resulted once again in the formation of 
CblNO as shown in Fig. 3b by the increase in absorbance at 
476 nm from 1100 to 1400 min.
A blank experiment was performed in the absence of 
cobalamin in which solutions of nitrite and  HAsc− were 
mixed under exactly the same conditions as we used in the 
experiments with cobalamin. The absorbance maximum at 
262 nm which comes from  HAsc− decreases with time to 
reach the pre-reaction value after 20 h from the start of the 
reaction (Figure S2, Supporting Information). We ascribe 
these findings to slow side reactions between ascorbic acid 
and nitrite, and/or slow diffusion of oxygen into the sealed 
cuvettes over longer periods of time (see further discussion).
In addition, we could show that by changing the sequence 
of mixing the reagents this resulted in totally different spec-
tral changes. On mixing first  CblOH2 with  HAsc− (before 
addition of nitrite),  CblOH2 was fully reduced to Cbl(II) 
as shown in Fig. 4a. Subsequent addition of nitrite led to 
Fig. 2  Plot of absorbance 
at 476 nm vs. time for the 
reaction between  CblNO2 
(8.6 × 10−5 M, obtained by 
mixing  CblOH2 with  NO2−) 
and  HAsc− at pH 4.3 (0.1 M 
acetate buffer, 25 °C, Ar atmos-
phere). Concentration ratio for 
 [CblOH2]:[NO2−]:[HAsc−]: a 
1:5:10, b 1:5:20, c 1:10:20 and 
d 1:10:30
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Fig. 3  a Plot of absorbance at 
476 nm vs. time for the reaction 
between  CblNO2 and  HAsc−. 
b Plot of absorbance at 476 nm 
vs. time for the reaction between 
 CblNO2 and  HAsc− with the 
addition of extra  HAsc− after 
1100 min from the start of the 
reaction
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the rapid formation of  CblNO2 and not CblNO, i.e. Cbl(II) 
is oxidized to  CblOH2 which reacts rapidly with nitrite to 
form  CblNO2 followed by its reduction to CblNO (Fig. 4b). 
The CblNO complex remains stable for some time (Fig. 4c) 
before it slowly converts back to  CblNO2 due to the deple-
tion of ascorbate (Fig. 4d).
We also used  FeII(EDTA) as a very efficient trap for the 
intermediate formation of ·NO [6, 24]. On mixing typical 
concentrations of nitrite and ascorbate under Ar atmosphere 
and allowing them to react for 2 h, the addition of  FeII(edta) 
immediately resulted in the formation of Fe(edta)NO as 
shown in Figure S3 (Supporting Information). This is clear 
evidence for the intermediate formation of ·NO during the 
reduction of nitrite by ascorbate under the selected condi-
tions of this study.
The results reported above show that it is indeed pos-
sible to observe the formation of CblNO under milder 
reducing conditions with ascorbic acid at pH  <  5. In 
terms of the biological relevance of these findings, we 
repeated a series of measurements where the pH was sys-
tematically decreased from 7.2 to 5.0, to see where the 
changeover from Cbl(II) to CblNO as reaction product 
occurs. In these experiments a typical concentration ratio 
of  [CblOH2]:[NO2−]:[HAsc−] = 1:5:10 was selected as 
done in Fig. 2. On decreasing the pH the reaction product 
changed from only Cbl(II) (pH 7.2, Figure S4, Supporting 
Information) to a mixture of Cbl(II) and CblNO (pH 5.5, 
Figure S5, Supporting Information), to only CblNO (pH 5.0, 
Figure S6, Supporting Information). It follows that as we 
go to milder reducing conditions by lowering the pH, only 
Cbl(NO) is formed at pH ≤ 5.0, which must be related to the 
pH dependence of the redox potential for the two-electron 
ascorbic acid/dehydroascorbate transformation. Accord-
ing to the Pourbaix diagram for this transformation [18], 
the redox potential of  H2Asc at pH 0 is + 0.4 V, of  H2Asc/
HAsc− at pH 4.1 (pKa1) is + 0.16 V, for  HAsc− at pH 7.0 
(8.0) is + 0.07 (+ 0.04 V), and for  HAsc−/Asc2− at pH 11.3 
(pKa2) is − 0.15 V. These data clearly show the large change 
in redox potential to a significantly stronger reducing agent 
on increasing the pH of the solution.
The challenge now will be to find a biologically relevant 
reducing agent that under mild reaction conditions will 
reduce  CblNO2 to CblNO at pH 7.4.
Mechanistic interpretation
The results of this study have clearly demonstrated that it 
is possible to obtain stable solutions of CblNO in the pres-
ence of a reducing agent starting from  CblNO2 under well-
selected reaction conditions. The remaining question is how 
can we account for the different reaction steps observed?
Fig. 4  Spectral changes 
observed for the reaction 
between  CblOH2 (8.6 × 10−5 
M) and  HAsc− (8.6 × 10−4 
M) at pH 4.3 (0.1 M acetate 
buffer, 25 °C, Ar atmosphere: 
a), and for the reaction of 
Cbl(II) obtained in a with 
 NO2− (4.3 × 10−4 M; b, c and 
d) between 0 and 60 min (b), 
between 60 and 600 min (c) and 
between 600 and 1200 min from 
the start of the reaction (d). In a 
and b spectra are recorded every 
1 min, whereas in c and d  every 
30 min
300 400 500 600
0,0
0,5
1,0
1,5
A
bs
or
ba
nc
e
Wavelength/nm
300 400 500 600
0,0
0,5
1,0
A
bs
or
ba
nc
e
Wavelength/nm
300 400 500 600
0,0
0,5
1,0
A
bs
or
ba
nc
e
Wavelength/nm
300 400 500 600
0,0
0,5
1,0
1,5
A
bs
or
ba
nc
e
Wavelength/nm
(a) (b)
(c) (d)
382 JBIC Journal of Biological Inorganic Chemistry (2018) 23:377–383
1 3
Our initial idea was that coordinated nitrite can be reduced 
by ascorbic acid to form the nitroxyl complex CblNO, since 
this is what the observed spectral changes tell us, thus a direct 
reaction from  CblNO2 to CblNO. However, in these experi-
ments performed at a pH < 5 we noticed that the conversion 
of  CblNO2 to CblNO slowed down on increasing the nitrite 
concentration. In the presence of a large excess of nitrite, no 
reaction was observed at all. Thus, nitrite suppresses the for-
mation of CblNO, from which we can conclude that ascorbic 
acid cannot reduce coordinated nitrite. This means that the 
remaining low concentration of  CblOH2 in solution is reduced 
by the added  HAsc− as found in our earlier report [17] and 
presented in reactions (1) and (2), where DHAsc represents 
dehydroascorbate.
In a subsequent reaction, Cbl(II) can be oxidized by nitrite 
to form  CblOH2 and ·NO.
The  CblOH2 formed in reaction (3) is immediately reduced 
by  HAsc− in reactions (1) and (2) and the nitroxyl product is 
formed in the very fast radical coupling of Cbl(II) and ·NO 
(k = 7.4 x  108 M−1 s−1 [6]), reaction (4). Thus, reactions (1) to 
(4) account for the observation that CblNO was formed faster 
and remained for longer times in the reaction mixture when 
higher concentrations of  HAsc− were used, whereas increasing 
nitrite concentration slowed down the conversion of  CblNO2 to 
CblNO. At the point where ascorbic acid is depleted, CblNO 
can react with excess ·NO to yield  CblOH2 and  N2O, similar 
to that found for the reaction between free HNO and ·NO to 
form  NO2− and  N2O [25]. Subsequently,  CblOH2 is converted 
to  CblNO2, the final reaction product in the presence of excess 
nitrite.
There are some side reactions (5) and (6) that can contrib-
ute to the formation of ·NO on a longer timescale and add 
to the redox cycling that causes the overall decomposition of 
ascorbic acid to DHAsc and the reformation of  CblNO2. These 
reactions have been known for almost 60 years [26].
In this case, the produced ·NO will react rapidly with 
Cbl(II) to form CblNO in reaction (4).
In addition, traces of oxygen can oxidize ·NO to ·NO2 and 
reform nitrite according to reactions (7)–(9).
(1)CblOH2 + HAsc− → Cbl(II) + Asc⋅−
(2)CblOH2 + Asc⋅− → Cbl(II) + DHAsc
(3)Cbl(II) + NO−2 → CblOH2 + ⋅NO
(4)Cbl(II) + ⋅NO → CblNO
(5)NO−2 + HAsc
−⋅
→
⋅
NO + Asc⋅−
(6)NO−2 + Asc
⋅−
→
⋅
NO + DHAsc
(7)2⋅NO + O2 → 2⋅NO2
(8)⋅NO + ⋅NO2 → N2O3
Reactions (5)–(9) can account for the reformation of 
nitrite and  CblNO2, as well as the overall depletion of ascor-
bic acid from the solution over longer reaction times.
Traces of oxygen can also oxidize Cbl(II) to form 
 CblOH2, which in turn will be reduced by  HAsc− back to 
Cbl(II) [27–29], by which more ascorbic acid will be used. 
But at the same time, oxygen will be reduced to form super-
oxide, peroxide and  OH·, which are stronger oxidants and 
can account for more redox cycling to occur during which 
ascorbic acid will be depleted, reactions (10)–(12). Finally, 
CblNO can also react with dioxygen to form  CblNO2 and 
 CblOH2 in a complex process involving  OH· and ·NO2 inter-
mediates [15].
The overall reaction sequence for the redox cycling of 
 CblNO2, CblNO and  CblOH2 in the presence of ascorbate is 
presented in Scheme 3. The main redox cycling components 
are marked in red and blue, whereas the oxidation of ascor-
bate in green. Complications caused by traces of oxygen that 
could not be avoided over very long reaction times are not 
included in the scheme for clarity reasons, but are given in 
reactions (7)–(12).
The suggested reaction sequence in Scheme 3 is based on 
a one-electron reduction process by which nitrite is reduced 
to ·NO by ascorbate. From the recent literature [30, 31] it is 
known that free ·NO can be reduced by ascorbic acid to form 
HNO, which in turn can react with  CblOH2 to form CblNO. 
Brasch and coworkers [32] demonstrated that using Angeli’s 
salt  (HN2O3−) as source of HNO, the formation of CblNO 
(9)N2O3 + H2O → 2HONO ⇄ 2H+ + 2NO−2
(10)Cbl(II) + O2 → CblOH2 + O−2
(11)Cbl(II) + O−
2
→ CblOH
2
+ O2−
2
(12)O2−
2
+ H+ ⇄ HO−
2
+ H+ ⇄ H
2
O
2
→ 2OH
⋅
Scheme  3  Overall reaction sequence for the redox cycling of 
 CblNO2, CblNO and  CblOH2 in the presence of ascorbate
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can occur at pH > 10.8, where the rate-determining step is 
the release of HNO by Angeli’s salt, such that no mecha-
nistic details about the mechanism of the reaction between 
 CblOH2/CblOH and HNO/NO− could be revealed. At pre-
sent, it is questionable whether further reduction of ·NO to 
HNO and a direct reaction of  CblOH2 with HNO to form 
CblNO can account for the results presented in this study.
All in all, our goal to find suitable reaction conditions to 
produce CblNO from  CblNO2 in the presence of a reducing 
agent over a long period of time was successful and has 
added to the overall understanding of the complex reaction 
system.
Conclusions
The reaction of  CblNO2, one of the naturally occurring 
forms of cobalamin, with ascorbate has been studied by 
UV–Vis spectroscopy. The present study provides mechanis-
tic information on this reaction at pH < 5. Under this condi-
tion, the only product of the reaction is CblNO. However, for 
the reduction of  CblNO2 by ascorbate, no direct evidence for 
the reduction of coordinated nitrite could be found. On the 
contrary, we showed that excess of nitrite suppressed the for-
mation of CblNO, from which we can conclude that ascorbic 
acid/ascorbate cannot reduce coordinated nitrite. We sug-
gest that the studied system is not just a simple reaction, but 
a rather complex chemical process. During the reaction of 
ascorbic acid with nitrocobalamin, the first products formed 
are the reduced form of Vitamin  B12 (Cbl(II)) and nitric 
oxide (·NO) that subsequently react rapidly to form CblNO. 
Our results show that the studied reactions are extremely 
oxygen sensitive due to the reverse oxidation of both Cbl(II) 
and CblNO to  CblOH2 and  CblNO2, respectively.
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